IPERIONX (IPX) director details sizeable share and award holdings on Form 3

Rhea-AI Filing Summary

IPERIONX Ltd director Hannigan Todd has filed an initial Form 3 reporting his existing equity interests in the company. The filing lists direct ownership of 25,403,109 Ordinary Shares, 454,464 Restricted Stock Units, and 50,000 American Depository Shares, each ADS representing ten Ordinary Shares traded on NASDAQ.

He also holds performance rights over 306,302 underlying IPX Ordinary Shares at each of A$6, A$7, and A$8 exercise prices, expiring in April 2030. Footnotes state that 159,334 units vest in December 2026 and 295,130 vest in April 2028, highlighting a structured, long-term incentive position rather than new market transactions.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Hannigan Todd

Role Director

Type	Security	Shares	Price	Value
holding	Performance Rights (A$6)	--	--	--
holding	Performance Rights (A$7)	--	--	--
holding	Performance Rights (A$8)	--	--	--
holding	Ordinary Shares	--	--	--
holding	Restricted Stock Units	--	--	--
holding	American Depository Shares	--	--	--

Holdings After Transaction: Performance Rights (A$6) — 306,302 shares (Direct); Performance Rights (A$7) — 306,302 shares (Direct); Performance Rights (A$8) — 306,302 shares (Direct); Ordinary Shares — 25,403,109 shares (Direct); Restricted Stock Units — 454,464 shares (Direct); American Depository Shares — 50,000 shares (Direct)

Footnotes (1)

1. 159,334 vest in December 2026; 295,130 vest in April 2028 American Depository Shares are traded on the NASDAQ. One American Depository Share is convertible into ten Ordinary Shares. (Ordinary Shares are traded on the Australian Stock Exchange) Ordinary Shares are traded on the Australian Stock Exchange. (ASX) Six Australian Dollars Seven Australian Dollars Eight Australian Dollars

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hannigan Todd

(Last) (First) (Middle)

1092 CONFROY DRIVE

(Street)

SOUTH BOSTON VIRGINIA 24592

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/19/2026

3. Issuer Name and Ticker or Trading Symbol
IPERIONX Ltd [ IPX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(3)	25,403,109	D
Restricted Stock Units	454,464(1)	D
American Depository Shares(2)	50,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Rights (A$6)	04/10/2029	04/10/2030	IPX Ordinary Shares	306,302	$6(4)	D
Performance Rights (A$7)	04/10/2029	04/10/2030	IPX Ordinary Shares	306,302	$7(5)	D
Performance Rights (A$8)	04/10/2029	04/10/2030	IPX Ordinary Shares	306,302	$8(6)	D

Explanation of Responses:

1. 159,334 vest in December 2026; 295,130 vest in April 2028

2. American Depository Shares are traded on the NASDAQ. One American Depository Share is convertible into ten Ordinary Shares. (Ordinary Shares are traded on the Australian Stock Exchange)

3. Ordinary Shares are traded on the Australian Stock Exchange. (ASX)

4. Six Australian Dollars

5. Seven Australian Dollars

6. Eight Australian Dollars

	Samantha Birdsong Manning	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does IPERIONX (IPX) director Hannigan Todd report on this Form 3?

The Form 3 shows existing holdings by director Hannigan Todd, including Ordinary Shares, Restricted Stock Units, American Depository Shares, and performance rights. It establishes his baseline ownership position in IPERIONX Ltd without reporting any new share purchases or sales.

How many IPERIONX (IPX) Ordinary Shares does Hannigan Todd hold directly?

The filing lists 25,403,109 Ordinary Shares held directly by Hannigan Todd. These shares trade on the Australian Stock Exchange and represent his core equity stake in IPERIONX Ltd as reported in this initial insider ownership statement.

What derivative or performance-based awards are disclosed for IPERIONX (IPX)?

The Form 3 discloses performance rights over 306,302 underlying IPX Ordinary Shares at each of A$6, A$7, and A$8 exercise prices. These rights expire in April 2030 and provide longer-term upside exposure linked to future share performance.

What vesting schedule is mentioned in the IPERIONX (IPX) Form 3 footnotes?

Footnotes state that 159,334 units vest in December 2026 and 295,130 vest in April 2028. This schedule underscores that a meaningful portion of the director’s incentive awards is tied to achieving medium- to long-term service and performance milestones.

How are IPERIONX (IPX) American Depository Shares described in the filing?

The filing notes that American Depository Shares trade on NASDAQ, with each ADS convertible into ten Ordinary Shares. It reports 50,000 ADS held, giving the director U.S.-listed exposure alongside his ASX-traded Ordinary Share holdings.